AMWA Webinar Series: The COVID-19 Vaccine – Your Questions Answered
Coming up in the AMWA webinar series:
WEBINAR TWO COVID-19 Vaccine Approval: Fast and Fabulous
Presented by Joanna Kirman, Associate Professor and immunologist in the Department of Microbiology and Immunology at Otago University and also the Director of First Year Health Sciences. Jo received a PhD from Otago in 1999 in infectious diseases immunology and was a Fogerty International Fellow at the Vaccine Research Center at the National Institutes of Health (USA). She returned to New Zealand and led the Infectious Diseases Group at the Malaghan Institute in Wellington before taking up her current role at Otago University in 2012. Her lab’s research is focused on understanding the generation and maintenance of immunological memory to improve vaccination against tuberculosis (TB). Jo is a member of the Bill & Melinda Gate Foundation Collaboration for TB vaccine Development.
Joanna's presentation will cover:
- Global regulatory bodies and why each country needs to go through a different approval process
- The NZ and Australian processes and regulatory bodies
- Discussion around prioritisation and rolling approvals in the approval process
When: Thursday, March 11 at 7pm (AEDT)*
*please note – this is a pre-recorded webinar
Cost: FREE for AMWA members; $20 for non-members
WEBINAR THREE Vaccine Implementation
March 18 - further details TBC
WEBINAR FOUR Reporting on Vaccination Without Increasing Hesitancy
Presented by Professor Julie Leask, Faculty of Medicine and Health, University of Sydney. March 25 - further details TBC
WEBINAR FIVE COVID-19 Diagnostic Testing Post-vaccine.
Presented by Dean Whiting, CEO Pathology Technology Australia. April 8 - further details TBC
WEBINAR SIX Equitable Access to Vaccines
Further details TBC
Past webinars in the series:
WEBINAR ONE COVID-19 Vaccines: Successes and Remaining Challenges, Thursday March 4
Presented by Professor Jamie Triccas, Director of the Infection, Immunity and Inflammation Program in the School of Medical Sciences, University of Sydney.
Jamie is a bacteriologist who uses a multidisciplinary approach to define immunity to chronic bacterial pathogens and develop new treatments to control infection. His group has progressed tuberculosis vaccines from the initial discovery phase (e.g. antigen discovery) to the development of products that are being prepared for clinical trials. These vaccine platforms are being applied to the development of novel COVID-19 vaccines, in particular to combat emerging viral variants. He has also established vaccine programs for important Cystic Fibrosis pathogens, in particular Pseudomonas aeruginosa and Mycobacterium abscesses. In recent years he has diversified his research program to include drug discovery and development for important human pathogens, involving a large network of national and international collaborators, with a focus on tuberculosis.
Jamie's presentation will cover:
- How vaccines work and the goal of COVID-19 vaccination programs
- The major COVID-19 vaccines and their mode of action
- Ongoing challenges in COVID-19 vaccination, such as global vaccine distribution and the emergence of new viral variants
A recording of Jamie's presentation is available in the Members Area
Thank you to our generous sponsors